LogicBio Therapeutics (LOGC) Misses Q4 EPS by 52c

March 5, 2026 5:35 PM

LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.52).

For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.